ProRx LLC recalls Tirzepatide Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Tirzepatide Injection
- Company
- ProRx LLC
- Where it was sold
-
TX and UT
States: Texas, Utah
- Units affected
- 2,761 vials
- About this recall
- Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03